
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Tagra Biotechnologies, since its inception in 1998, focuses on the development and manufacturing of microencapsulated ingredients such as vitamins, oils, sunscreen agents, pigments, and others. Tagra is the first company to patent a unique innovative Release on DemandTM (RNDTM) Microencapsulation Technology. Tagras platform addresses industry challenges of stability, efficiency, and compatibility with other ingredients in cosmetic and pharmaceutical formulations. The technology enables masking, protection, and releases of more than 40 actives and pigments widely used in cosmetics and OTC preparations. Tagras microcapsules are friction released through consumer application. Tagra also owns and operates its own plant and state of the...
Microencapsulation,release on demand technology,raw materials,encapsulated pigments,and encapsulated actives
Tagra biotechnologies operates in the Personal care product manufacturing industry.
Tagra biotechnologies's revenue is 11m - 100m
Tagra biotechnologies has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.